{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:51:41Z","timestamp":1792039901565,"version":"4.4.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1038\/ncpneph0035","type":"journal-article","created":{"date-parts":[[2005,11,24]],"date-time":"2005-11-24T16:10:45Z","timestamp":1132848645000},"page":"98-114","source":"Crossref","is-referenced-by-count":245,"title":["Mechanisms of Disease: pre-eclampsia"],"prefix":"10.1038","volume":"1","author":[{"given":"Marina","family":"Noris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneph0035_CR1","doi-asserted-by":"crossref","unstructured":"National High Blood Pressure Education Program Working Group on High Pressure in Pregnancy (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183: S1\u2013S22","DOI":"10.1067\/mob.2000.107928"},{"key":"BFncpneph0035_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/jwh.1.1999.8.495","volume":"8","author":"N Mahmoudi","year":"1999","unstructured":"Mahmoudi N et al. (1999) Eclampsia: A 13-year experience at a United States tertiary care center. J Womens Health Gender Based Med 8: 495\u2013500","journal-title":"J Womens Health Gender Based Med"},{"key":"BFncpneph0035_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0002-9378(00)70324-3","volume":"182","author":"M de Swiet","year":"2000","unstructured":"de Swiet M (2000) Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol 182: 760\u2013766","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","volume":"169","author":"BM Sibai","year":"1993","unstructured":"Sibai BM et al. (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169: 1000\u20131006","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR5","first-page":"189","volume-title":"Preeclampsia","author":"K Villar","year":"2003","unstructured":"Villar K et al. (2003) Eclampsia and pre-eclampsia: a health problem for 2000 years. In Preeclampsia, 189\u2013207 (Eds Critchley H et al.) London: RCOG Press"},{"key":"BFncpneph0035_CR6","first-page":"181","volume":"102","author":"BM Sibai","year":"2003","unstructured":"Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102: 181\u2013192","journal-title":"Obstet Gynecol"},{"key":"BFncpneph0035_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1590\/S0100-879X2001001000001","volume":"34","author":"P L\u00f2pez-Jaramillo","year":"2001","unstructured":"L\u00f2pez-Jaramillo P et al. (2001) Preeclamplsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 34: 1227\u20131235","journal-title":"Braz J Med Biol Res"},{"key":"BFncpneph0035_CR8","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/ajcn\/33.10.2202","volume":"33","author":"JM Beliz\u00e0n","year":"1980","unstructured":"Beliz\u00e0n JM and Villar J (1980) The relationship between calcium intake and edema-proteinuria and hypertension-gestosis: a hypothesis. Am J Clin Nutr 33: 2202\u20132210","journal-title":"Am J Clin Nutr"},{"key":"BFncpneph0035_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/oxfordjournals.aje.a010122","volume":"151","author":"D Li","year":"2000","unstructured":"Li D and Wi S (2000) Changing paternity and the risk of preeclampsia in the subsequent pregnancy. Am J Epidemiol 151: 57\u201362","journal-title":"Am J Epidemiol"},{"key":"BFncpneph0035_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa011379","volume":"346","author":"R Skjaerven","year":"2002","unstructured":"Skjaerven R et al. (2002) The interval between pregnancies and the risk of preeclampsia. N Engl J Med 346: 33\u201338","journal-title":"N Engl J Med"},{"key":"BFncpneph0035_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0165-0378(03)00051-2","volume":"59","author":"G Dekker","year":"2003","unstructured":"Dekker G and Robillard PY (2003) The birth interval hypothesis: does it really indicate the end of the primipaternity hypothesis? J Reprod Immunol 59: 245\u2013251","journal-title":"J Reprod Immunol"},{"key":"BFncpneph0035_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt K and Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330: 565","journal-title":"BMJ"},{"key":"BFncpneph0035_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bmj.330.7491.549","volume":"330","author":"F Milne","year":"2005","unstructured":"Milne F et al. (2005) The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 330: 549\u2013550","journal-title":"BMJ"},{"key":"BFncpneph0035_CR14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(00)02800-2","volume":"356","author":"JJ Walker","year":"2000","unstructured":"Walker JJ (2000) Pre-eclampsia. Lancet 356: 1260\u20131265","journal-title":"Lancet"},{"key":"BFncpneph0035_CR15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1210\/jcem.87.4.8405","volume":"87","author":"M Wolf","year":"2002","unstructured":"Wolf M et al. (2002) First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 87: 1563\u20131568","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0035_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM199901073400102","volume":"340","author":"M Kupferminc","year":"1999","unstructured":"Kupferminc M et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340: 9\u201313","journal-title":"N Engl J Med"},{"key":"BFncpneph0035_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0002-9378(76)90626-8","volume":"125","author":"T Brewer","year":"1976","unstructured":"Brewer T (1976) Role of malnutrition in pre-eclampsia and eclampsia. Am J Obstet Gynecol 125: 281\u2013282","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR18","first-page":"224","volume":"93","author":"GJ Hofmeyr","year":"2003","unstructured":"Hofmeyr GJ et al. (2003) Calcium supplementation to prevent pre-eclampsia\u2014a systemic review. S Afr Med J 93: 224\u2013228","journal-title":"S Afr Med J"},{"key":"BFncpneph0035_CR19","first-page":"CD001059","volume":"2002","author":"AN Atallah","year":"2002","unstructured":"Atallah AN et al. (2002) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2002: CD001059","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 5","key":"BFncpneph0035_CR20","doi-asserted-by":"publisher","first-page":"S1375","DOI":"10.1093\/ajcn\/71.5.1375s","volume":"71","author":"J Villar","year":"2000","unstructured":"Villar J and Belizan JM (2000) Same nutrient, different hypotheses: disparities in trials of calcium supplementation during pregnancy. Am J Clin Nutr 71 (Suppl 5): S1375\u2013S1379","journal-title":"Am J Clin Nutr"},{"key":"BFncpneph0035_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ng0593-59","volume":"4","author":"K Ward","year":"1993","unstructured":"Ward K et al. (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4: 59\u201361","journal-title":"Nat Genet"},{"key":"BFncpneph0035_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1086\/514843","volume":"61","author":"R Arngrimsson","year":"1997","unstructured":"Arngrimsson R et al. (1997) Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 61: 354\u2013362","journal-title":"Am J Hum Genet"},{"key":"BFncpneph0035_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","volume":"175","author":"D Dizon-Townson","year":"1996","unstructured":"Dizon-Townson D et al. (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175: 902\u2013905","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/jmg.34.6.525","volume":"34","author":"S Sohda","year":"1997","unstructured":"Sohda S et al. (1997) Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 34: 525\u2013526","journal-title":"J Med Genet"},{"key":"BFncpneph0035_CR25","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/01.HYP.33.6.1338","volume":"33","author":"K O'Shaughnessy","year":"1999","unstructured":"O'Shaughnessy K et al. (1999) Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 33: 1338\u20131341","journal-title":"Hypertension"},{"key":"BFncpneph0035_CR26","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/hmg\/8.9.1799","volume":"8","author":"R Arngrimsson","year":"1999","unstructured":"Arngrimsson R et al. (1999) A genome-wide scan reveals a maternal susceptibility locus for preeclampsia on chromosome 2p13. Hum Mol Genet 8: 1799\u20131805","journal-title":"Hum Mol Genet"},{"key":"BFncpneph0035_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1086\/345311","volume":"72","author":"H Laivuori","year":"2003","unstructured":"Laivuori H et al. (2003) Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet 72: 168\u2013177","journal-title":"Am J Hum Genet"},{"key":"BFncpneph0035_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/sj.ejhg.5200706","volume":"9","author":"AM Lachmeijer","year":"2001","unstructured":"Lachmeijer AM et al. (2001) A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet 9: 758\u2013764","journal-title":"Eur J Hum Genet"},{"key":"BFncpneph0035_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1086\/316888","volume":"67","author":"EK Moses","year":"2000","unstructured":"Moses EK et al. (2000) A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 67: 1581\u20131585","journal-title":"Am J Hum Genet"},{"key":"BFncpneph0035_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/molehr\/gah080","volume":"10","author":"CB Oudejans","year":"2004","unstructured":"Oudejans CB et al. (2004) The parent-of-origin-effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol Hum Reprod 10: 589\u2013598","journal-title":"Mol Hum Reprod"},{"key":"BFncpneph0035_CR31","doi-asserted-by":"crossref","unstructured":"van Dijk M et al.: Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet, in press","DOI":"10.1038\/ng1541"},{"key":"BFncpneph0035_CR32","doi-asserted-by":"crossref","unstructured":"GOPEC Consortium (2005) Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 77: 127\u2013131","DOI":"10.1086\/431245"},{"key":"BFncpneph0035_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1067\/mob.2000.108865","volume":"183","author":"RJ Levine","year":"2000","unstructured":"Levine RJ et al. (2000) Should the definition of preeclampsia include a rise in diastolic blood pressure of >\/= 15 mm Hg in association with proteinuria? Am J Obstet Gynecol 183: 787\u2013792","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR34","doi-asserted-by":"publisher","first-page":"IX","DOI":"10.3109\/10641950109152635","volume":"20","author":"MA Brown","year":"2001","unstructured":"Brown MA et al. (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: a statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregn 20: IX\u2013XIV","journal-title":"Hypertens Pregn"},{"key":"BFncpneph0035_CR35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/01.AOG.0000118311.18958.63","volume":"103","author":"JJ Waugh","year":"2004","unstructured":"Waugh JJ et al. (2004) Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol 103: 769\u2013777","journal-title":"Obstet Gynecol"},{"key":"BFncpneph0035_CR36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","volume":"103","author":"BM Sibai","year":"2004","unstructured":"Sibai BM (2004) Diagnosis, controversies, and management of HELLP syndrome. Obstet Gynecol 103: 981\u2013991","journal-title":"Obstet Gynecol"},{"key":"BFncpneph0035_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/jmf.16.5.275.279","volume":"16","author":"W Yamasmit","year":"2004","unstructured":"Yamasmit W et al. (2004) Random urinary protein-to-creatinine ratio for prediction of significant proteinuria in women with preeclampsia. J Matern Fetal Neonatal Med 16: 275\u2013279","journal-title":"J Matern Fetal Neonatal Med"},{"key":"BFncpneph0035_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1479-828X.2000.tb01136.x","volume":"40","author":"MA Brown","year":"2000","unstructured":"Brown MA et al. (2000) The detection, investigation and management of hypertension in pregnancy: executive summary. Aust NZ J Obstet Gynecol 40: 133\u2013138","journal-title":"Aust NZ J Obstet Gynecol"},{"key":"BFncpneph0035_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00006250-200208000-00029","volume":"100","author":"BM Sibai","year":"2002","unstructured":"Sibai BM (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100: 369\u2013377","journal-title":"Obstet Gynecol"},{"key":"BFncpneph0035_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0020-7292(02)80002-9","volume":"77","author":"LC Gilstrap III","year":"2002","unstructured":"Gilstrap LC III and Ramin SM on behalf of the ACOG Committee on Practice Bulletin (2002) Diagnosis and management of preeclampsia and eclampsia. Int J Obstet Gynecol 77: 67\u201375","journal-title":"Int J Obstet Gynecol"},{"key":"BFncpneph0035_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.semnephrol.2004.07.008","volume":"24","author":"P Moran","year":"2004","unstructured":"Moran P et al. (2004) The renal response to preeclampsia. Semin Nephrol 24: 588\u2013595","journal-title":"Semin Nephrol"},{"key":"BFncpneph0035_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.semnephrol.2004.07.007","volume":"24","author":"JU Hibbard","year":"2004","unstructured":"Hibbard JU et al. (2004) Cardiovascular changes in preeclampsia. Semin Nephrol 24: 580\u2013587","journal-title":"Semin Nephrol"},{"key":"BFncpneph0035_CR43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjcard.2003.11.065","volume":"93","author":"L Haukkamaa","year":"2004","unstructured":"Haukkamaa L et al. (2004) Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 93: 805\u2013808","journal-title":"Am J Cardiol"},{"key":"BFncpneph0035_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1081\/PRG-120021066","volume":"22","author":"J Zhang","year":"2003","unstructured":"Zhang J et al. (2003) Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregn 22: 203\u2013212","journal-title":"Hypertens Pregn"},{"key":"BFncpneph0035_CR45","first-page":"24","volume":"95","author":"JC Hauth","year":"2000","unstructured":"Hauth JC et al. (2000) Pregnancy outcomes in healthy nulliparous women who subsequently developed hypertension. Obstet Gynecol 95: 24\u201328","journal-title":"Obstet Gynecol"},{"key":"BFncpneph0035_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1067\/mob.2002.120080","volume":"186","author":"A Buchbinder","year":"2002","unstructured":"Buchbinder A et al. (2002) Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 186: 66\u201371","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/bmb\/ldg005","volume":"67","author":"L Duley","year":"2003","unstructured":"Duley L (2003) Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull 67: 161\u2013176","journal-title":"Br Med Bull"},{"key":"BFncpneph0035_CR48","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/01.AOG.0000147599.47713.5d","volume":"104","author":"A Conde-Agudelo","year":"2004","unstructured":"Conde-Agudelo A et al. (2004) World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 104: 1367\u20131391","journal-title":"Obstet Gynecol"},{"key":"BFncpneph0035_CR49","first-page":"257","volume-title":"Preeclampsia","author":"RA North","year":"2003","unstructured":"North RA (2003) Can we predict pre-eclampsia? In Preeclampsia, 257\u2013275 (Eds Critchley H et al.) London: RCOG Press"},{"key":"BFncpneph0035_CR50","first-page":"9","volume":"31","author":"R Axt-Fliedner","year":"2004","unstructured":"Axt-Fliedner R (2004) Second trimester uterine artery Doppler ultrasound as a screening test for adverse pregnancy outcome. Clin Exp Obstet Gynecol 31: 9\u201311","journal-title":"Clin Exp Obstet Gynecol"},{"key":"BFncpneph0035_CR51","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI200422991","volume":"114","author":"K Red-Horse","year":"2004","unstructured":"Red-Horse K et al. (2004) Trophoblast differentiation during embryo implantation and formation of the maternal\u2013fetal interface. J Clin Invest 114: 744\u2013754","journal-title":"J Clin Invest"},{"issue":"Suppl A","key":"BFncpneph0035_CR52","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.placenta.2005.02.010","volume":"26","author":"F Lyall","year":"2005","unstructured":"Lyall F (2005) Priming and remodelling of human placental bed spiral arteries during pregnancy\u2014a review. Placenta 26 (Suppl A): S31\u2013S36","journal-title":"Placenta"},{"key":"BFncpneph0035_CR53","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1172\/JCI119388","volume":"99","author":"Y Zhou","year":"1997","unstructured":"Zhou Y et al. (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: One cause of defective endovascular invasion in this syndrome? J Clin Invest 99: 2152\u20132164","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR54","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1471-0528.1991.tb13450.x","volume":"98","author":"R Pijnenborg","year":"1991","unstructured":"Pijnenborg R et al. (1991) Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 98: 648\u2013655","journal-title":"Br J Obstet Gynaecol"},{"key":"BFncpneph0035_CR55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1053\/plac.2002.0946","volume":"24","author":"M Kadyrov","year":"2003","unstructured":"Kadyrov M et al. (2003) Preeclampsia and maternal anemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 24: 540\u2013548","journal-title":"Placenta"},{"key":"BFncpneph0035_CR56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","volume":"189","author":"JS Moldenhauer","year":"2003","unstructured":"Moldenhauer JS et al. (2003) The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 189: 1173\u20131177","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0002-9378(85)80170-8","volume":"152","author":"F Teasdale","year":"1985","unstructured":"Teasdale F (1985) Histomorphometry of the human placenta in maternal preeclampsia. Am J Obstet Gynecol 152: 25\u201331","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR58","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nri886","volume":"2","author":"A Moffett-King","year":"2002","unstructured":"Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2: 656\u2013663","journal-title":"Nat Rev Immunol"},{"key":"BFncpneph0035_CR59","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1084\/jem.20041783","volume":"200","author":"P Parham","year":"2004","unstructured":"Parham P (2004) NK cells and trophoblasts: partners in pregnancy. J Exp Med 200: 951\u2013955","journal-title":"J Exp Med"},{"key":"BFncpneph0035_CR60","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1084\/jem.20041214","volume":"200","author":"SE Hiby","year":"2004","unstructured":"Hiby SE et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200: 957\u2013965","journal-title":"J Exp Med"},{"key":"BFncpneph0035_CR61","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1172\/JCI119387","volume":"99","author":"Y Zhou","year":"1997","unstructured":"Zhou Y et al. (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99: 2139\u20132151","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR62","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1530\/jrf.0.0990609","volume":"99","author":"A Sharkey","year":"1993","unstructured":"Sharkey A et al. (1993) Expression of vascular endothelial growth factor in human placenta. J Reprod Fertil 99: 609\u2013615","journal-title":"J Reprod Fertil"},{"key":"BFncpneph0035_CR63","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62567-9","volume":"160","author":"Y Zhou","year":"2002","unstructured":"Zhou Y et al. (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160: 1405\u20131423","journal-title":"Am J Pathol"},{"key":"BFncpneph0035_CR64","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/j.1471-0528.1996.tb09627.x","volume":"103","author":"J Cooper","year":"1996","unstructured":"Cooper J et al. (1996) VEGF mRNA levels in placentae from pregnancies complicated by preeclampsia. Br J Obstet Gynaecol 103: 1191\u20131196","journal-title":"Br J Obstet Gynaecol"},{"key":"BFncpneph0035_CR65","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"R Levine","year":"2004","unstructured":"Levine R et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672\u2013683","journal-title":"N Engl J Med"},{"key":"BFncpneph0035_CR66","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"S Maynard","year":"2003","unstructured":"Maynard S et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649\u2013658","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR67","doi-asserted-by":"publisher","first-page":"15637","DOI":"10.1073\/pnas.2635424100","volume":"100","author":"M Hirashima","year":"2003","unstructured":"Hirashima M et al. (2003) Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta. Proc Natl Acad Sci USA 100: 15637\u201315642","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneph0035_CR68","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/JCI119868","volume":"100","author":"A Papapetropoulos","year":"1997","unstructured":"Papapetropoulos A et al. (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131\u20133139","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR69","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S and Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002\u20132012","journal-title":"N Engl J Med"},{"key":"BFncpneph0035_CR70","first-page":"208","volume":"18","author":"C Baylis","year":"1998","unstructured":"Baylis C et al. (1998) Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin Nephrol 18: 208\u2013230","journal-title":"Semin Nephrol"},{"key":"BFncpneph0035_CR71","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/humrep\/12.11.2546","volume":"12","author":"AJ Thomson","year":"1997","unstructured":"Thomson AJ et al. (1997) Nitric oxide synthase activity and localization do not change in uterus and placenta during human parturition. Hum Reprod 12: 2546\u20132552","journal-title":"Hum Reprod"},{"key":"BFncpneph0035_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/plac.1999.0428","volume":"21","author":"D Martin","year":"2000","unstructured":"Martin D and Conrad KP (2000) Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta 21: 23\u201331","journal-title":"Placenta"},{"key":"BFncpneph0035_CR73","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0143-4004(95)90000-4","volume":"16","author":"AL Eis","year":"1995","unstructured":"Eis AL et al. (1995) Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta 16: 113\u2013126","journal-title":"Placenta"},{"key":"BFncpneph0035_CR74","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1440-1681.2003.03844.x","volume":"30","author":"SJ Orange","year":"2003","unstructured":"Orange SJ et al. (2003) Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin Exp Pharmacol Physiol 30: 376\u2013381","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFncpneph0035_CR75","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0002-9440(10)65363-1","volume":"154","author":"F Lyall","year":"1999","unstructured":"Lyall F et al. (1999) Human trophoblast invasion and spiral artery transformation. The role of nitric oxide. Am J Pathol 154: 1105\u20131114","journal-title":"Am J Pathol"},{"key":"BFncpneph0035_CR76","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1071\/RD01036","volume":"13","author":"V Novaro","year":"2001","unstructured":"Novaro V et al. (2001) Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod Fertil Dev 13: 411\u2013420","journal-title":"Reprod Fertil Dev"},{"key":"BFncpneph0035_CR77","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1097\/01.ASN.0000135975.90889.60","volume":"15","author":"JM Davison","year":"2004","unstructured":"Davison JM et al. (2004) New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 15: 2440\u20132448","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0035_CR78","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/S0002-9440(10)65089-4","volume":"156","author":"C Dunk","year":"2000","unstructured":"Dunk C et al. (2000) Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 156: 2185\u20132199","journal-title":"Am J Pathol"},{"key":"BFncpneph0035_CR79","first-page":"779","volume":"76","author":"A Ahmed","year":"1997","unstructured":"Ahmed A et al. (1997) Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76: 779\u2013791","journal-title":"Lab Invest"},{"key":"BFncpneph0035_CR80","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.placenta.2004.06.002","volume":"26","author":"CC Chang","year":"2005","unstructured":"Chang CC et al. (2005) Induction of VE-cadherin in rat placental trophoblasts by VEGF through a NO-dependent pathway. Placenta 26: 234\u2013241","journal-title":"Placenta"},{"key":"BFncpneph0035_CR81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00041552-199607000-00010","volume":"5","author":"M Noris","year":"1996","unstructured":"Noris M et al. (1996) The role of vasoactive molecules of endothelial origin in the pathophysiology of normal pregnancy and pregnancy-induced hypertension. Curr Opin Nephrol Hypertens 5: 347\u2013352","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFncpneph0035_CR82","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0003-9861(91)90224-7","volume":"288","author":"R Radi","year":"1991","unstructured":"Radi R et al. (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481\u2013487","journal-title":"Arch Biochem Biophys"},{"key":"BFncpneph0035_CR83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0002-9440(10)64733-5","volume":"156","author":"A Many","year":"2000","unstructured":"Many A et al. (2000) Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 156: 321\u2013331","journal-title":"Am J Pathol"},{"key":"BFncpneph0035_CR84","doi-asserted-by":"publisher","first-page":"16899","DOI":"10.1074\/jbc.M000301200","volume":"275","author":"W Wang","year":"2000","unstructured":"Wang W et al. (2000) Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J Biol Chem 275: 16899\u201316903","journal-title":"J Biol Chem"},{"key":"BFncpneph0035_CR85","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1073\/pnas.93.13.6770","volume":"93","author":"Y Xia","year":"1996","unstructured":"Xia Y et al. (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93: 6770\u20136774","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneph0035_CR86","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1073\/pnas.95.16.9220","volume":"95","author":"J Vasquez-Vivar","year":"1998","unstructured":"Vasquez-Vivar J et al. (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220\u20139225","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneph0035_CR87","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.1073\/pnas.94.13.6954","volume":"94","author":"Y Xia","year":"1997","unstructured":"Xia Y and Zweier JL (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94: 6954\u20136958","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneph0035_CR88","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.HYP.0000116220.39793.c9","volume":"43","author":"M Noris","year":"2004","unstructured":"Noris M et al. (2004) L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 43: 614\u2013622","journal-title":"Hypertension"},{"key":"BFncpneph0035_CR89","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1152\/ajpcell.2001.280.5.C1130","volume":"280","author":"H Li","year":"2001","unstructured":"Li H et al. (2001) Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthases in endothelial cells. Am J Physiol 280: E75\u2013E82","journal-title":"Am J Physiol"},{"key":"BFncpneph0035_CR90","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1006\/niox.2000.0296","volume":"4","author":"D Lowe","year":"2000","unstructured":"Lowe D (2000) Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4: 441\u2013458","journal-title":"Nitric Oxide"},{"key":"BFncpneph0035_CR91","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.0001-6349.2005.00493.x","volume":"84","author":"SM Carlsen","year":"2005","unstructured":"Carlsen SM et al. (2005) Early second-trimester maternal hyperandrogenemia and subsequent preeclampsia: a prospective study. Acta Obstet Gynecol Scand 84: 117\u2013121","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BFncpneph0035_CR92","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.HYP.0000129825.52269.9e","volume":"44","author":"A Germain","year":"2004","unstructured":"Germain A et al. (2004) Evidence supporting a beneficial role for long term L-arginine supplementation in high risk pregnancies. Hypertension 44: e1","journal-title":"Hypertension"},{"key":"BFncpneph0035_CR93","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S0002-9378(94)70179-2","volume":"170","author":"M Molnar","year":"1994","unstructured":"Molnar M et al. (1994) Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 170: 1458\u20131466","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR94","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejogrb.2004.04.033","volume":"118","author":"HM Tanir","year":"2005","unstructured":"Tanir HM et al. (2005) Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester. Eur J Obstet Gynecol Reprod Biol 118: 190\u2013195","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl A","key":"BFncpneph0035_CR95","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1053\/plac.2002.0815","volume":"23","author":"I Caniggia","year":"2002","unstructured":"Caniggia I and Winter JL (2002) Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies\u2014A review. Placenta 23 (Suppl A): S47\u2013S57","journal-title":"Placenta"},{"key":"BFncpneph0035_CR96","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.placenta.2004.02.011","volume":"25","author":"A Rajakumar","year":"2004","unstructured":"Rajakumar A et al. (2004) Evidence of the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 25: 763\u2013769","journal-title":"Placenta"},{"key":"BFncpneph0035_CR97","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1172\/JCI8316","volume":"105","author":"I Caniggia","year":"2000","unstructured":"Caniggia I et al. (2000) Hypoxia-inducible factor-1 mediates biological effects of oxygen in human trophoblast differentiation through TGF\u03b23 . J Clin Invest 105: 577\u2013587","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR98","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1172\/JCI6380","volume":"103","author":"I Caniggia","year":"1999","unstructured":"Caniggia I et al. (1999) Inhibition of TGF\u03b23 restores the invasive capability of extravillous trophoblast in preeclamptic pregnancies. J Clin Invest 103: 1641\u20131650","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR99","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/01.RES.0000024411.22110.AA","volume":"90","author":"T-H Hung","year":"2002","unstructured":"Hung T-H et al. (2002) Hypoxia-reoxygenation. A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90: 1274\u20131281","journal-title":"Circ Res"},{"key":"BFncpneph0035_CR100","first-page":"G768","volume":"254","author":"D Parks","year":"1988","unstructured":"Parks D et al. (1988) Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 254: G768\u2013G774","journal-title":"Am J Physiol"},{"key":"BFncpneph0035_CR101","first-page":"92","volume-title":"Hypertensive Disorders in Pregnancy","author":"MK McLaughlin","year":"1999","unstructured":"McLaughlin MK and Roberts JM (1999) Hemodynamic changes in pregnancy. In Hypertensive Disorders in Pregnancy, 92\u201395 (Eds Lindheimer MD et al.) Stamford: Appleton & Lange"},{"key":"BFncpneph0035_CR102","doi-asserted-by":"publisher","first-page":"F614","DOI":"10.1152\/ajprenal.00410.2003","volume":"288","author":"D Shah","year":"2005","unstructured":"Shah D (2005) Role of the renin\u2013angiotensin system in the pathogenesis of preeclampsia. Am J Renal Physiol 288: F614\u2013F625","journal-title":"Am J Renal Physiol"},{"key":"BFncpneph0035_CR103","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1471-0528.2003.02030.x","volume":"110","author":"L Bowyer","year":"2003","unstructured":"Bowyer L et al. (2003) Forearm blood flow in pre-eclampsia. BJOG 110: 383\u2013391","journal-title":"BJOG"},{"key":"BFncpneph0035_CR104","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s004040000104","volume":"264","author":"A Elsheikh","year":"2001","unstructured":"Elsheikh A et al. (2001) The renin-aldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet 264: 182\u2013185","journal-title":"Arch Gynecol Obstet"},{"key":"BFncpneph0035_CR105","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","volume":"70","author":"S Walsh","year":"2004","unstructured":"Walsh S (2004) Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 70: 223\u2013232","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"BFncpneph0035_CR106","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","volume":"171","author":"SP Seligman","year":"1994","unstructured":"Seligman SP et al. (1994) The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171: 944\u2013948","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR107","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1042\/cs0930413","volume":"93","author":"JV Garmendia","year":"1997","unstructured":"Garmendia JV et al. (1997) Nitric oxide in different types of hypertension during pregnancy. Clin Sci 93: 413\u2013421","journal-title":"Clin Sci"},{"key":"BFncpneph0035_CR108","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0140-6736(93)92335-Q","volume":"34","author":"SA Fickling","year":"1993","unstructured":"Fickling SA et al. (1993) Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 34: 242\u2013243","journal-title":"Lancet"},{"key":"BFncpneph0035_CR109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1471-0528.1996.tb09512.x","volume":"103","author":"P Lopez-Jaramillo","year":"1996","unstructured":"Lopez-Jaramillo P et al. (1996) Cyclic guanosidine 3,5 monophosphate concentrations in pre-eclampsia: effects of hydralazine. Br J Obstet Gynaecol 103: 33\u201338","journal-title":"Br J Obstet Gynaecol"},{"key":"BFncpneph0035_CR110","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00006254-200209000-00023","volume":"57","author":"G Pridjian","year":"2002","unstructured":"Pridjian G and Puschett JB (2002) Preeclampsia. Part 1: Clinical and pathophysiologic considerations. Obstet Gynecol Surv 57: 598\u2013618","journal-title":"Obstet Gynecol Surv"},{"key":"BFncpneph0035_CR111","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajog.2004.12.052","volume":"192","author":"CS Buhimschi","year":"2005","unstructured":"Buhimschi CS et al. (2005) Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 192: 734\u2013741","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR112","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJM200411183512123","volume":"351","author":"H Stepan","year":"2004","unstructured":"Stepan H et al. (2004) Soluble fms-like tyrosine kinase 1. N Engl J Med 351: 2241\u20132242","journal-title":"N Engl J Med"},{"key":"BFncpneph0035_CR113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajog.2005.03.016","volume":"193","author":"M Wolf","year":"2005","unstructured":"Wolf M et al. (2005) Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 193: 16\u201322","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR114","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1172\/JCI18015","volume":"111","author":"A Luttun","year":"2003","unstructured":"Luttun A and Carmeliet P (2003) Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? J Clin Invest 111: 600\u2013602","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR115","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.placenta.2004.05.004","volume":"26","author":"H Li","year":"2005","unstructured":"Li H et al. (2005) Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 26: 210\u2013217","journal-title":"Placenta"},{"key":"BFncpneph0035_CR116","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1067\/mob.2000.108022","volume":"183","author":"JC Livingston","year":"2000","unstructured":"Livingston JC et al. (2000) Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 183: 1554\u20131557","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR117","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jama.293.1.77","volume":"293","author":"RJ Levine","year":"2005","unstructured":"Levine RJ et al. (2005) Urinary placental growth factor and risk of preeclampsia. JAMA 293: 77\u201385","journal-title":"JAMA"},{"key":"BFncpneph0035_CR118","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0002-9440(10)61731-2","volume":"159","author":"Y Masuda","year":"2001","unstructured":"Masuda Y et al. (2001) Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159: 599\u2013608","journal-title":"Am J Pathol"},{"key":"BFncpneph0035_CR119","doi-asserted-by":"publisher","first-page":"12605","DOI":"10.1074\/jbc.C300012200","volume":"278","author":"H Sugimoto","year":"2003","unstructured":"Sugimoto H et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605\u201312608","journal-title":"J Biol Chem"},{"key":"BFncpneph0035_CR120","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa021491","volume":"349","author":"J Yang","year":"2003","unstructured":"Yang J et al. (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349: 427\u2013434","journal-title":"N Engl J Med"},{"key":"BFncpneph0035_CR121","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina V et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707\u2013716","journal-title":"J Clin Invest"},{"key":"BFncpneph0035_CR122","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0140-6736(87)90960-3","volume":"2","author":"P Boyd","year":"1987","unstructured":"Boyd P et al. (1987) Pre-eclampsia and trisomy 13: a possible association. Lancet 2: 425\u2013427","journal-title":"Lancet"},{"issue":"Suppl 2","key":"BFncpneph0035_CR123","first-page":"S196A","volume":"12","author":"Y Bdolah","year":"2005","unstructured":"Bdolah Y et al. (2005) Trisomy 13 and preeclampsia: an old link with a new explanation. J Soc Gynecol Invest 12 (Suppl 2): S196A","journal-title":"J Soc Gynecol Invest"},{"key":"BFncpneph0035_CR124","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nm0901-1003","volume":"7","author":"S AbdAlla","year":"2001","unstructured":"AbdAlla S et al. (2001) Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7: 1003\u20131009","journal-title":"Nat Med"},{"key":"BFncpneph0035_CR125","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","volume":"101","author":"R Dechend","year":"2000","unstructured":"Dechend R et al. (2000) AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101: 2382\u20132387","journal-title":"Circulation"},{"key":"BFncpneph0035_CR126","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.amjhyper.2004.10.002","volume":"18","author":"SM Bobst","year":"2005","unstructured":"Bobst SM et al. (2005) Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 18: 330\u2013336","journal-title":"Am J Hypertens"},{"key":"BFncpneph0035_CR127","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S1071-5576(02)00259-9","volume":"10","author":"Y Xia","year":"2003","unstructured":"Xia Y et al. (2003) Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 10: 82\u201393","journal-title":"J Soc Gynecol Investig"},{"key":"BFncpneph0035_CR128","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/0002-9378(89)90778-3","volume":"161","author":"C Hubel","year":"1989","unstructured":"Hubel C et al. (1989) Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 161: 1025\u20131034","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR129","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/01.CIR.0000051367.92927.07","volume":"107","author":"F Cosentino","year":"2003","unstructured":"Cosentino F et al. (2003) High glucose causes upregulation of cyclooxygenase-2 and all prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017\u20131023","journal-title":"Circulation"},{"key":"BFncpneph0035_CR130","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","volume":"354","author":"L Chappell","year":"1999","unstructured":"Chappell L et al. (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 354: 810\u2013816","journal-title":"Lancet"},{"key":"BFncpneph0035_CR131","first-page":"202","volume":"6","author":"F Facchinetti","year":"1999","unstructured":"Facchinetti F et al. (1999) L-Arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Invest 6: 202\u2013207","journal-title":"J Soc Gynecol Invest"},{"key":"BFncpneph0035_CR132","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2362.2005.01445.x","volume":"35","author":"K Rytlewski","year":"2005","unstructured":"Rytlewski K et al. (2005) Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 35: 32\u201337","journal-title":"Eur J Clin Invest"},{"key":"BFncpneph0035_CR133","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1067\/mob.2002.125735","volume":"187","author":"L Chappell","year":"2002","unstructured":"Chappell L et al. (2002) Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol 187: 777\u2013784","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR134","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.semnephrol.2004.07.004","volume":"24","author":"JM Roberts","year":"2004","unstructured":"Roberts JM and Speer P (2004) Antioxidant therapy to prevent preeclampsia. Semin Nephrol 24: 557\u2013564","journal-title":"Semin Nephrol"},{"key":"BFncpneph0035_CR135","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1471-0528.2005.00675.x","volume":"112","author":"WD Fraser","year":"2005","unstructured":"Fraser WD et al. (2005) The vitamin E debate: implications for ongoing trials of pre-eclampsia prevention. BJOG 112: 684\u2013688","journal-title":"BJOG"},{"key":"BFncpneph0035_CR136","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B et al. (2005) Pre-eclampsia. Lancet 365: 785\u2013799","journal-title":"Lancet"},{"key":"BFncpneph0035_CR137","first-page":"518","volume":"11","author":"W Mautner","year":"1962","unstructured":"Mautner W et al. (1962) Preeclamptic nephropathy. An electron microscopic study. Lab Invest 11: 518\u2013530","journal-title":"Lab Invest"},{"key":"BFncpneph0035_CR138","first-page":"327","volume-title":"Chesley's Hypertensive Disorders in Pregnancy","author":"E Gallery","year":"1999","unstructured":"Gallery E and Lindheimer M (1999) Pathology and pathophysiology of preeclampsia: Alterations in volume homeostasis. In Chesley's Hypertensive Disorders in Pregnancy, 327\u2013347 (Eds Lindheimer M et al.) Stamford: Appleton & Lange"},{"key":"BFncpneph0035_CR139","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0002-9378(56)90582-8","volume":"71","author":"T Hayashi","year":"1956","unstructured":"Hayashi T (1956) Uric acid and endogenous creatinine clearance studies in normal pregnancy and toxemias of pregnancy. Am J Obstet Gynecol 71: 859\u2013870","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR140","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s002619900571","volume":"24","author":"R Zissin","year":"1999","unstructured":"Zissin R et al. (1999) Hepatic infarction in preeclampsia as part of the HELLP syndrome: CT appearance. Abdom Imaging 24: 594\u2013596","journal-title":"Abdom Imaging"},{"key":"BFncpneph0035_CR141","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1148\/radiographics.18.2.9536483","volume":"18","author":"J Port","year":"1998","unstructured":"Port J and Beauchamp NJ (1998) Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18: 353\u2013367","journal-title":"Radiographics"},{"key":"BFncpneph0035_CR142","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF02718370","volume":"251","author":"A Saleh","year":"1992","unstructured":"Saleh A et al. (1992) Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch Gynecol Obstet 251: 105\u2013110","journal-title":"Arch Gynecol Obstet"},{"key":"BFncpneph0035_CR143","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0002-9378(86)90803-3","volume":"155","author":"T Stubbs","year":"1986","unstructured":"Stubbs T et al. (1986) Evidence of accelerated platelet production and consumption in non thrombocytopenic preeclampsia. Am J Obstet Gynecol 155: 263\u2013265","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpneph0035_CR144","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajog.2005.03.017","volume":"193","author":"MD Lindheimer","year":"2005","unstructured":"Lindheimer MD (2005) Unraveling the mysteries of preeclampsia. Am J Obstet Gynecol 193: 3\u20134","journal-title":"Am J Obstet Gynecol"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0035","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:10:57Z","timestamp":1684440657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":144,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BFncpneph0035"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0035","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}